Calcium Signaling Pathways Mediating Synaptic Potentiation Triggered by Amyotrophic Lateral Sclerosis IgG in Motor Nerve Terminals

Sporadic amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that affects particularly motoneurons. Several pieces of evidence suggested the involvement of autoimmune mechanisms mediated by antibodies in ALS. However, the significance of those antibodies in the disease and the underlying mechanisms are unknown. Here we showed that IgG purified from a group of sporadic ALS patients, but not familial ALS patients, specifically interact with the presynaptic membrane of motoneurons through an antigen–antibody interaction and modulated synaptic transmission. Immunoreactivity against nerve terminals showed strong correlation with synaptic modulation ability. In addition, several controls have ruled out the possibility for this synaptic modulation to be mediated through proteases or nonspecific effects. Effective IgG potentiated both spontaneous and asynchronous transmitter release. Application of pharmacological inhibitors suggested that activation of this increased release required a nonconstitutive Ca2+ influx through N-type (Cav2.2) channels and phospholipase C activity and that activation of IP3 and ryanodine receptors were necessary to both activate and sustain the increased release. Consistent with the notion that ALS is heterogeneous disorder, our results reveal that, in ∼50% of ALS patients, motor nerve terminals constitutes a target for autoimmune response.

Novel Molecular Biomarkers at the Blood-Brain Barrier in ALS

Motoneuron Death Triggered by a Specific Pathway Downstream of Fas

The Inositol Trisphosphate/Calcium Signaling Pathway in Health and

The Inositol Trisphosphate/Calcium Signaling Pathway in Health and

The role of mitochondria in amyotrophic lateral sclerosis

Recruitment of the Mitochondrial-Dependent Apoptotic Pathway in

calcium/calcium-mediated signaling pathwayRat Genome Database

Frontiers Amyotrophic Lateral Sclerosis (ALS) and Adenosine

Targeting synapse function and loss for treatment of

Complement activation at the motor end-plates in amyotrophic

Calcium Signaling Pathways Mediating Synaptic Potentiation

Nuclear calcium signalling in the regulation of brain function

Frontiers Microglia in Alzheimer's disease: pathogenesis

ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors